<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02606162</url>
  </required_header>
  <id_info>
    <org_study_id>NI 13018</org_study_id>
    <secondary_id>2014-A01371-46</secondary_id>
    <nct_id>NCT02606162</nct_id>
  </id_info>
  <brief_title>Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort</brief_title>
  <acronym>CROSS</acronym>
  <official_title>Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the outcomes of severe osteoporotic fractures
      hospitalized in France, the risk of incident severe fracture at 2 years and 5 years and the
      risk of mortality over 2 and 5 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In France, the burden of osteoporotic fractures has been studied using cross sectional data
      from the French hospital national database. The availability of fracture liaison service in
      the main French cities allows the recruitment of a high number of these targeted patients. A
      large national multicenter, longitudinal, prospective cohort of patients hospitalized for
      severe osteoporotic fracture, the CROSS cohort (&quot;Cohorte sur les Risques d'une OStéoporose
      Sévère&quot;), in order to update data on prognosis (refracture, mortality), epidemiology and of
      severe osteoporotic fractures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2016</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of new severe fracture over 2 years</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the incidence of new severe fracture over 2 years in patients hospitalized for a severe fracture</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of new severe fracture over 5 years</measure>
    <time_frame>5 years</time_frame>
    <description>To assess the incidence of new severe fracture over 5 years in patients hospitalized for a severe fracture</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality rate</measure>
    <time_frame>2 years</time_frame>
    <description>To study the risk of mortality over 2 years</description>
  </other_outcome>
  <other_outcome>
    <measure>Mortality rate</measure>
    <time_frame>5 years</time_frame>
    <description>To study the risk of mortality over 5 years</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of severe fracture</measure>
    <time_frame>3 months after inclusion and each year during 5 years</time_frame>
    <description>To study the role of refracture on mortality after adjustment for prefracture health status
To study the risk factors and phenotypes of patients hospitalized for severe fracture and to compare them between each type of severe fracture (hip,subtrochanteric, vertebrae, pelvis, humerus)</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of patients who receive antiosteoporotic treatments and/or calcium and/or vitamin D and/or falls prevention</measure>
    <time_frame>3 months after inclusion and each year during 5 years</time_frame>
    <description>To check the implementation of 2012 French guidelines, including on the basis on number of performed bone densitometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life assessed by questionnaire Euroqol (EQ5D) and questionnaire (SF-36)</measure>
    <time_frame>3 months after inclusion and each year during 5 years</time_frame>
    <description>To assess and compare the quality of life between each type of severe fracture</description>
  </other_outcome>
  <enrollment type="Anticipated">2200</enrollment>
  <condition>Severe Fragility Fracture</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Men and women hospitalized for severe fragility fractures in response to low-energy trauma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women aged above 60 years, living in France and hospitalized for severe
             fragility fractures in response to low-energy trauma (e.g., a fall from standing
             height).

          -  Vertebral fractures have to be confirmed by an X ray examination.

          -  To be eligible for the study the patient has to be included and interviewed within 6
             weeks of the fracture event.

          -  Informed and free consent given and form signed and dated

        Exclusion Criteria:

          -  Non severe fracture (for example wrist fracture), pathological fractures, high trauma
             fractures and per prosthetic fractures.

          -  Non registration with a social security scheme (holder or beneficiary).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karine BRIOT, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karine BRIOT, MD, PhD</last_name>
    <phone>+33 1 41 25 53</phone>
    <email>karine.briot@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clotilde SIMON</last_name>
    <phone>+ 33 01 58 41 11 90</phone>
    <email>clotilde.simon@cch.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karine BRIOT, MD, PhD</last_name>
      <phone>+01 58 41 25 53</phone>
      <email>karine.briot@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2015</study_first_submitted>
  <study_first_submitted_qc>November 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2015</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Osteoporotic Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

